This is a competing renewal of a training program that was initially funded in 1999. Since its inception, the primary goal of this training program has been to prepare promising pre-doctoral students for successful careers in nutritional sciences, with a focus on nutrition as a modulator of metabolic disease (obesity, diabetes), cancer, neurodegenerative disease, and cardiovascular disease. In this renewal we capitalize upon our unique academic structure of a recently merged Department of Pharmacology and Nutritional Sciences to provide a multi-disciplinary program where graduate students are trained to develop nutritional and/or pharmacologic approaches towards the prevention and treatment of chronic diseases. The need for highly trained scientists capable of conducting multidisciplinary research in this area has become critical with the increased prevalence of metabolic diseases in the U.S., and the growing recognition that metabolic disorders underlie chronic diseases including cancer, neurodegenerative disease, and cardiovascular disease. We envision that scientists who receive cross-training in nutrition and pharmacology through this multidisciplinary program will have the necessary skill set to tackle these common yet complex disease processes. Twenty-nine training faculty who routinely employ nutritional and/or pharmacologic approaches to understand the metabolic basis of disease will provide training around 4 theme areas (obesity/diabetes, cardiovascular disease, cancer, neuroscience/aging). The goals of the Multidisciplinary Approaches for Metabolic Diseases Training Program are to provide support to a talented and diverse population of graduate students through stipends and individual development plans (IDPs) to prepare them for biomedical careers in the area of metabolic diseases; to provide innovative, multidisciplinary education to promote the essential skills for conducting outstanding research using nutrition and pharmacology-based approaches; to provide a core faculty of established and productive researchers who will serve as mentors and role models for the trainees; to provide a broad-based yet cohesive research environment for trainees, thus fostering further interdisciplinary research; and to provide training in the ethcal conduct of high quality research.

Public Health Relevance

Disorders in metabolism are a common feature of most chronic diseases, especially those on the rise in prevalence in the US. We propose to train future scientists to identify ways to use pharmacological (drugs) and nutritional approaches to prevent and treat metabolic disease based-disorders, including obesity/diabetes, cancer, cardiovascular disease and neurodegenerative disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
2T32DK007778-16
Application #
8851863
Study Section
Kidney, Urologic and Hematologic Diseases D Subcommittee (DDK)
Program Officer
Densmore, Christine L
Project Start
2000-08-15
Project End
2020-07-31
Budget Start
2015-08-01
Budget End
2016-07-31
Support Year
16
Fiscal Year
2015
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Pharmacology
Type
Schools of Medicine
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Frazier, Hilaree N; Maimaiti, Shaniya; Anderson, Katie L et al. (2017) Calcium's role as nuanced modulator of cellular physiology in the brain. Biochem Biophys Res Commun 483:981-987
Maimaiti, Shaniya; Frazier, Hilaree N; Anderson, Katie L et al. (2017) Novel calcium-related targets of insulin in hippocampal neurons. Neuroscience 364:130-142
Anderson, Katie L; Frazier, Hilaree N; Maimaiti, Shaniya et al. (2017) Impact of Single or Repeated Dose Intranasal Zinc-free Insulin in Young and Aged F344 Rats on Cognition, Signaling, and Brain Metabolism. J Gerontol A Biol Sci Med Sci 72:189-197
Hoffman, Jessie B; Petriello, Michael C; Hennig, Bernhard (2017) Impact of nutrition on pollutant toxicity: an update with new insights into epigenetic regulation. Rev Environ Health 32:65-72
Helsley, Robert N; Zhou, Changcheng (2017) Epigenetic impact of endocrine disrupting chemicals on lipid homeostasis and atherosclerosis: a pregnane X receptor-centric view. Environ Epigenet 3:
Petriello, Michael C; Hoffman, Jessie B; Morris, Andrew J et al. (2017) Emerging roles of xenobiotic detoxification enzymes in metabolic diseases. Rev Environ Health 32:105-110
Jiang, Jieyun; Creasy, Kate Townsend; Purnell, Justin et al. (2017) Zhx2 (zinc fingers and homeoboxes 2) regulates major urinary protein gene expression in the mouse liver. J Biol Chem 292:6765-6774
Wei, Xiaowei; Xu, Yong; Xu, Fang Fang et al. (2017) RelB Expression Determines the Differential Effects of Ascorbic Acid in Normal and Cancer Cells. Cancer Res 77:1345-1356
Wahlang, Banrida; Perkins, Jordan T; Petriello, Michael C et al. (2017) A compromised liver alters polychlorinated biphenyl-mediated toxicity. Toxicology 380:11-22
Hargis, Kendra E; Blalock, Eric M (2017) Transcriptional signatures of brain aging and Alzheimer's disease: What are our rodent models telling us? Behav Brain Res 322:311-328

Showing the most recent 10 out of 57 publications